We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Show more
This release has made a correction to a release issued under the same headline on August 14, 2024, by HCW Biologics, Inc. (NASDAQ: HCWB), to show the amount included in the condensed interim...
MIRAMAR, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0392 | -6.75862068966 | 0.58 | 0.6824 | 0.4903 | 21936 | 0.58333245 | CS |
4 | 0.0752 | 16.1512027491 | 0.4656 | 0.7037 | 0.42 | 34872 | 0.57604243 | CS |
12 | -0.0592 | -9.86666666667 | 0.6 | 0.7144 | 0.4 | 16899 | 0.5689088 | CS |
26 | -1.1592 | -68.1882352941 | 1.7 | 1.93 | 0.4 | 18454 | 0.83179698 | CS |
52 | -1.5492 | -74.1244019139 | 2.09 | 2.14 | 0.4 | 17550 | 1.10238166 | CS |
156 | -3.0492 | -84.9359331476 | 3.59 | 7.05 | 0.4 | 277322 | 4.36728217 | CS |
260 | -6.9592 | -92.7893333333 | 7.5 | 7.51 | 0.4 | 268506 | 4.38778685 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions